Print

Lay Description

• To determine the optimal time to initiate anticoagulation with a Non-Vitamin K Oral Anticoagulant (NOAC) after ischemic stroke in patients with non-valvular atrial fibrillation.

Secondary Objectives:

  • To compare the rates of primary adverse outcomes in a per protocol analysis
  • To compare 30 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups
  • To compare 30 day clinical outcomes by the PROMIS-10 scale among the time-to-treatment groups.
  • To compare 90 day clinical outcomes by the modified Rankin scale among the time-to-treatment groups
  • To explore the optimal timing in subgroups of age, sex, outcome category, and NOAC choice

Category

  • Heart, Vascular and Blood
IRB Number
20180802HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact

Regulatory Point of Contact
David Pillow
david.pillow@utsa.edu

Regulatory Point of Contact
Donald McGeary
(210) 567-5454
mcgeary@uthscsa.edu

Overall Recruitment Point of Contact
David Pillow
david.pillow@utsa.edu

Principal Investigator
Donald McGeary